Library of second-generation cycloruthenated compounds and evaluation of their biological properties as potential anticancer drugs: Passing the nanomolar barrier

Cyclometalated Ru Complexes of Type [RuII(N∧N)2(C∧N)]z: Physicochemical Response to Substituents Installed on the Anionic Ligand

(2010) Paolo G. Bomben et al.   INORGANIC CHEMISTRY

Organometallic Anticancer Compounds

(2010) Gilles Gasser et al.   JOURNAL OF MEDICINAL CHEMISTRY

A Ruthenium-Containing Organometallic Compound Reduces Tumor Growth through Induction of the Endoplasmic Reticulum Stress Gene CHOP

(2009) Xiangjun Meng et al.   CANCER RESEARCH

A categorization of metal anticancer compounds based on their mode of action

(2009) Teresa Gianferrara et al.   DALTON TRANSACTIONS

Areneruthenium complexes as anticancer agents

(2009) Georg Süss-Fink   DALTON TRANSACTIONS

Cycloruthenated Compounds - Synthesis and Applications

(2009) Jean-Pierre Djukic et al.   EUROPEAN JOURNAL OF INORGANIC CHEMISTRY

Redox Chemistry and Electronic Properties of 2,3,5,6-Tetrakis(2-pyridyl)pyrazine-Bridged Diruthenium Complexes Controlled byN,C,N′-BisCyclometalated Ligands

(2009) Sipke H. Wadman et al.   INORGANIC CHEMISTRY

Consequences ofN,C,N′- andC,N,N′-Coordination Modes on Electronic and Photophysical Properties of Cyclometalated Aryl Ruthenium(II) Complexes

(2009) Sipke H. Wadman et al.   INORGANIC CHEMISTRY

Cyclometalated ruthenium(II) complexes of benzo[h]quinoline (bzqH)[Ru(bzq)(NCMe)4]+, [Ru(bzq)(LL)(NCMe)2]+, and [Ru(bzq)(LL)2]+ (LL=bpy, phen)

(2009) Ronan Le Lagadec et al.   INORGANICA CHIMICA ACTA

Recent developments in ruthenium anticancer drugs

(2009) Aviva Levina et al.   Metallomics

Synthesis of functionalized 2-arylpyridines from 2-halopyridines and various aryl halides via a nickel catalysis

(2009) Corinne Gosmini et al.   TETRAHEDRON

Elevated copper and oxidative stress in cancer cells as a target for cancer treatment

(2008) Anshul Gupte et al.   CANCER TREATMENT REVIEWS

Bioorganometallic chemistry—from teaching paradigms to medicinal applications

(2008) Christian G. Hartinger et al.   CHEMICAL SOCIETY REVIEWS

Cellular Uptake, Cytotoxicity, and Metabolic Profiling of Human Cancer Cells Treated with Ruthenium(II) Polypyridyl Complexes [Ru(bpy)2(NN)]Cl2with NN=bpy, phen, dpq, dppz, and dppn

(2008) Ulrich Schatzschneider et al.   ChemMedChem

Mechanistic Study of Acetate-Assisted C−H Activation of 2-Substituted Pyridines with [MCl2Cp*]2(M = Rh, Ir) and [RuCl2(p-cymene)]2

(2008) Youcef Boutadla et al.   ORGANOMETALLICS

Electron-transfer activated metal-based anticancer drugs

(2006) Erwin Reisner et al.   INORGANICA CHIMICA ACTA